Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 26% ± 9% | |
| classical monocyte | 4 studies | 41% ± 11% | |
| hematopoietic precursor cell | 4 studies | 46% ± 9% | |
| myeloid cell | 4 studies | 41% ± 23% | |
| capillary endothelial cell | 4 studies | 20% ± 5% | |
| smooth muscle cell | 3 studies | 22% ± 6% | |
| hematopoietic stem cell | 3 studies | 26% ± 2% | |
| neutrophil | 3 studies | 31% ± 13% | |
| endothelial cell of vascular tree | 3 studies | 27% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 27% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1613.74 | 651 / 653 | 98% | 33.08 | 591 / 605 |
| breast | 100% | 2832.94 | 459 / 459 | 97% | 23.75 | 1080 / 1118 |
| prostate | 100% | 1813.07 | 245 / 245 | 96% | 14.12 | 483 / 502 |
| lung | 100% | 2468.44 | 576 / 578 | 95% | 17.24 | 1092 / 1155 |
| skin | 94% | 1578.33 | 1705 / 1809 | 99% | 59.05 | 465 / 472 |
| brain | 94% | 772.09 | 2472 / 2642 | 98% | 24.92 | 694 / 705 |
| stomach | 97% | 1275.32 | 350 / 359 | 91% | 15.61 | 261 / 286 |
| intestine | 100% | 2091.77 | 964 / 966 | 88% | 13.02 | 464 / 527 |
| adrenal gland | 97% | 982.76 | 251 / 258 | 90% | 19.67 | 207 / 230 |
| bladder | 100% | 2102.57 | 21 / 21 | 87% | 15.04 | 436 / 504 |
| uterus | 99% | 1552.39 | 168 / 170 | 82% | 22.81 | 377 / 459 |
| kidney | 99% | 1324.99 | 88 / 89 | 79% | 35.88 | 708 / 901 |
| esophagus | 85% | 1418.63 | 1234 / 1445 | 92% | 15.80 | 168 / 183 |
| ovary | 94% | 987.99 | 170 / 180 | 64% | 10.34 | 276 / 430 |
| pancreas | 47% | 240.92 | 154 / 328 | 94% | 21.99 | 168 / 178 |
| adipose | 100% | 3155.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 172.87 | 80 / 80 |
| peripheral blood | 99% | 6051.39 | 921 / 929 | 0% | 0 | 0 / 0 |
| spleen | 99% | 1891.53 | 238 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 21.46 | 44 / 45 |
| heart | 97% | 1144.95 | 835 / 861 | 0% | 0 | 0 / 0 |
| liver | 35% | 234.40 | 78 / 226 | 60% | 5.99 | 245 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 19.40 | 27 / 29 |
| blood vessel | 92% | 1091.13 | 1231 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 86% | 794.87 | 689 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001837 | Biological process | epithelial to mesenchymal transition |
| GO_0061572 | Biological process | actin filament bundle organization |
| GO_1900158 | Biological process | negative regulation of bone mineralization involved in bone maturation |
| GO_0048705 | Biological process | skeletal system morphogenesis |
| GO_0061182 | Biological process | negative regulation of chondrocyte development |
| GO_0032432 | Cellular component | actin filament bundle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0031005 | Molecular function | filamin binding |
| Gene name | RFLNB |
| Protein name | Alternative protein FAM101B Refilin-B (Regulator of filamin protein B) (RefilinB) |
| Synonyms | FAM101B |
| Description | FUNCTION: Involved in the regulation of the perinuclear actin network and nuclear shape through interaction with filamins. Plays an essential role in the formation of cartilaginous skeletal elements. . |
| Accessions | L0R6G5 Q8N5W9 ENST00000329099.4 ENST00000640199.2 |
